School of Pharmacy - News

Funding granted by the Research Council for Natural Sciences and Engineering to UEF researchers amounts to more than 2.1 million euros.

A rat model of early-stage Parkinson’s disease was characterised and utilised in the PhD study of Juuso Leikas, MSc (Pharm). A common anaesthetic, isoflurane, was shown to relieve Parkinson-like symptoms in the model.

The University of Eastern Finland’s research in atmospheric science, pharmacy, and tourism was ranked in the top 76–100 worldwide.

People with Alzheimer’s disease (AD) are less likely to have cataract surgery than people without Alzheimer’s disease. The procedure rate starts to decrease already one year after the diagnosis.

Dr. Eva del Amo has received the best publication award of 2020 from European Journal of Pharmaceutics and Biopharmaceutics (EJPB).

The aim of the new national competence network is to increase cooperation between universities, hospitals, and the business worlds and to make Finnish neuroscience know-how visible internationally.

A recent study by an international team of researchers may open up new opportunities for the treatment of liver cell cancer, i.e., hepatocellular carcinoma.

Collaboration will leverage University of Eastern Finland’s leading computational molecular simulation technology to identify novel therapeutic approaches and patient selection strategies as part of SpringWorks’ commitment to developing MAPK pathway targeted therapies.

The risks of an elective revascularisation procedure for coronary artery disease are similar for people with and without Alzheimer’s disease (AD), but people with AD have worse outcomes after an emergency procedure.